Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2010
02/25/2010WO2009152041A3 Controlled release formulations of pramipexole
02/25/2010WO2009149056A3 Combinations of niacin and an oxicam
02/25/2010WO2009142988A3 Chitin micro-particles as an adjuvant
02/25/2010WO2009133455A3 Pharmaceutical composition of clodipogrel
02/25/2010WO2009129494A4 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation
02/25/2010WO2009129460A3 Clonidine formulations in a biodegradable polymer carrier
02/25/2010WO2009126926A3 Anticancer methods employing extracts of gleditsia sinensis lam
02/25/2010WO2009089822A3 Use of an acetylsalicylic acid salt for the treatment of viral infections
02/25/2010WO2009086076A3 Particles for injection and processes for forming the same
02/25/2010WO2009086067A3 Particles for injection and processes fo forming the same
02/25/2010WO2009077599A3 Nanospheres with external surface of noble metal
02/25/2010WO2009077147A3 Pharmaceutical compositions
02/25/2010WO2009031006A3 Antiviral topical formulations in the form of a bio-adhesive gel
02/25/2010WO2009000286A8 Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
02/25/2010WO2008152626A3 Uniformly abrasive confectionery product and process therefor
02/25/2010WO2008126088A3 Anti-pyretic vasodilators
02/25/2010WO2008116636A8 Therapeutic plaster for trigger and acupuncture points and for meridian therapy
02/25/2010US20100049080 Thixotropic swallow challenge medium
02/25/2010US20100048735 Polyaminoacids functionalized wtih alpha-tocopherol, and uses thereof, especially therapeutic uses
02/25/2010US20100048659 Aqueous compositions containing metronidazole
02/25/2010US20100048526 Pharmaceutical composition for transdermal or transmucous administration
02/25/2010US20100048522 Ear infections, optionally with antiinflammatory agent
02/25/2010US20100048452 Injectable Sustained-Release Formulation Of Active Principles, And Process For The Preparation Thereof
02/25/2010US20100047435 Hydrogel Attached to Backing and Method for Making Same
02/25/2010US20100047364 Nutrient System for Individualized Responsive Dosing Regimens
02/25/2010US20100047359 Stable powder formulation containing a novel anticholinergic agent
02/25/2010US20100047358 Food protein and charged emulsifier interaction
02/25/2010US20100047357 Compositions for topical application comprising a peroxide and retinoid
02/25/2010US20100047356 Charge-assembled capsules for phototherapy
02/25/2010US20100047355 Magnetic resonance-detectable, ultrasound-detectable and/or radiopaque microcapsules and uses thereof
02/25/2010US20100047354 Combretum laurifolium mart. extract and methods of extracting and using such extract
02/25/2010US20100047353 Hair care composition
02/25/2010US20100047352 Compositions and methods for treating excessive bleeding
02/25/2010US20100047351 Treatment of stroke using isolated placental cells
02/25/2010US20100047349 Stabilized solid preparation
02/25/2010US20100047348 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
02/25/2010US20100047347 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
02/25/2010US20100047346 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
02/25/2010US20100047345 Hydrophobic abuse deterrent delivery system for hydromorphone
02/25/2010US20100047344 Performance enhancing composition and use thereof
02/25/2010US20100047343 Multiparticulate formulation having tramadol in immediate and controlled release form
02/25/2010US20100047342 Method and Composition for Administering an NMDA Receptor Antagonist to a Subject
02/25/2010US20100047341 Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory
02/25/2010US20100047340 Hot-melt extrusion of modified release multi-particulates
02/25/2010US20100047339 Compositions for the treatment of chronic degenerative inflammatory conditions
02/25/2010US20100047338 Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
02/25/2010US20100047337 Pharmaceutical spheroids
02/25/2010US20100047336 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration
02/25/2010US20100047335 Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
02/25/2010US20100047334 Ph sensitive liposome compositions for controlling surface topography and binding reactivity in functionalized liposomes
02/25/2010US20100047333 Modified Peptides and Their Use for the Treatment of Autoimmune Diseases
02/25/2010US20100047332 Treatments for burns using thyroid hormone compound in a human
02/25/2010US20100047331 Method of inducing neutralizing antibodies to human immunodeficiency virus
02/25/2010US20100047330 Treatment for dark adaptation
02/25/2010US20100047329 Novel Vaccination Carrier
02/25/2010US20100047328 Adhesive preparation
02/25/2010US20100047327 Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
02/25/2010US20100047326 Multiple-Compartment Applicator
02/25/2010US20100047325 Analgesic anti-inflammatory patches for topical use
02/25/2010US20100047323 Chitosan solution and medical preparation with chitosan coating formed from the solution
02/25/2010US20100047322 Combination antihypertensive wafer
02/25/2010US20100047321 Silver antimicrobial composition and use
02/25/2010US20100047320 Oral polymeric membrane feruloyl esterase producing bacteria formulation
02/25/2010US20100047319 Biodegradable Poly(Ester-Amide) And Poly(Amide) Coatings For Implantable Medical Devices With Enhanced Bioabsorption Times
02/25/2010US20100047318 Ceramic implants affording controlled release of active materials
02/25/2010US20100047314 Folinic acid derivatives for promoting bone growth
02/25/2010US20100047312 Use of bioactive and radiopaque material for stent coating
02/25/2010US20100047307 Injectable drug carrier comprising layered double hydroxide
02/25/2010US20100047306 Pharmaceutical compositions comprising bisphosponates
02/25/2010US20100047305 Extracellular Matrix Compositions
02/25/2010US20100047295 Skin care composition
02/25/2010US20100047294 Semi-finished product in the manufacture of a composition for skin or hair care
02/25/2010US20100047292 Methods of processing microparticles and compositions produced thereby
02/25/2010US20100047290 Functional protein crystals containing a core nano-particle and uses thereof
02/25/2010US20100047223 Pharmanutrient Composition(s) and System(s) for Individualized, Responsive Dosing Regimens
02/25/2010US20100047206 Powdery composition for nasal administration
02/25/2010US20100047190 Uses and methods for preventing and/or treating caries caused by mutants streptococci
02/25/2010US20100047189 Azeotrope-like compositions of 1,1,1,2-tetrafluoropropene and 1,1,1,2-tetrafluoroethane
02/25/2010US20100047188 Modulation of toll-like receptor 8 expression by antisense oligonucleotides
02/25/2010US20100047187 Methods of treating parkinson's disease using halogenated volatile compounds
02/25/2010US20100047186 Peptides and Their Use
02/25/2010US20100047185 Actvie substance combination
02/25/2010US20100047184 Pharmaceutical compositions containing an effervescent acid-base couple
02/25/2010US20100047180 Iron/Iron Oxide Nanoparticle and Use Thereof
02/25/2010US20100047179 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
02/25/2010US20100047178 Perylenequinone derivatives and uses thereof
02/25/2010US20100047162 Methods of processing multi-phasic dispersons
02/25/2010CA2735050A1 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof
02/25/2010CA2734972A1 An extended release pharmaceutical composition of entacapone or salts thereof
02/25/2010CA2734956A1 Lipid formulations comprising a thiolated antioxidant
02/25/2010CA2734917A1 Heterogeneous polymeric micelles for intracellular delivery
02/25/2010CA2734847A1 Novel excipient for mannitol tableting
02/25/2010CA2734788A1 Systems and devices for generating nitric oxide
02/25/2010CA2734763A1 Corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
02/25/2010CA2734687A1 Topical hydrogel composition
02/25/2010CA2734646A1 Hot-melt extrusion of modified release multi-particulates
02/25/2010CA2734442A1 Methods and compositions for oral administration of proteins
02/25/2010CA2734356A1 Improvements relating to nanodisperse compositions
02/25/2010CA2733180A1 Improvements in or relating to compositions
02/24/2010EP2157211A1 Bioactive metal nanomaterials stabilized by bioactive agents and preparation process
1 ... 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 ... 2991